Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache, nausea ...

In summary, the UCSF study suggests that extended courses of Paxlovid might help some individuals with long COVID, though ...

A study found that some long COVID patients who took Paxlovid saw improvement. But experts said the research isn't enough to ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Patients are reporting difficulties accessing the anti-COVID drug Paxlovid this winter, even as the coronavirus causing the infectious disease reaches levels not seen in months. Angela Carpio couldn’t ...

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines ...

Pfizer Inc. convinced a federal judge in Massachusetts to cancel a patent Enanta Pharmaceuticals Inc. alleges its blockbuster Covid-19 antiviral Paxlovid infringes. Enanta’s changes to the patent, ...

Enanta Pharmaceuticals plans to appeal a court decision that Pfizer's Covid-19 antiviral drug, Paxlovid, doesn't infringe on its own patents. The U.S. District Court of Massachusetts ruled that ...